1. Brody JE. Hard facts of hypertension elude too many. New York Times. June 25, 2004.
2. Kaplan NM. Hypertension in the population at large. In: Clinical Hypertension. Baltimore, MD: Williams and Wilkins; 1998.
3. Rakel RE. Conn’s Current Therapy. Philadelphia, PA: WB Saunders Company; 1993.
4. Sixth report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997 Nov 24;157(21):2413-46.
5. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52. Epub 2003 Dec 01.
6. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997 Apr 17;336(16):1117-24.
7. Bloom BS. Daily regimen and compliance with treatment. BMJ. 2001 Sep 22;323(7314):647.
8. Reyes AJ, Alcocer, L. Minding magnesium while treating essential hypertension with diuretics. In: Theophanides T, Anastassopoulou J. Magnesium: Current Status and New Developments: Theoretical, Biological, and Medical Aspects. 1st ed. Dordrecht, Netherlands: Kluwer Academic Publishers; 1997.
9. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium. 1984;3(46):30114.
10. Facts About Dietary Supplements (2001). NIH Clinical Center, National Institutes of Health. March 2001.
11. Rude RK. Magnesium deficiency: a cause of heterogeneous disease in humans. J Bone Miner Res. 1998 Apr;13(4):749-58.
12. Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons; 1996.
13. Cohen JS. High-dose oral magnesium in the treatment of chronic, intractable erythromelalgia. Ann Pharmacother. 2002 Feb;36(2):255-60.
14. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J. 1984 Jul;108(1):18893.
15. Leppert J, Myrdal U, Hedner T, Edvinsson L, Tracz Z, Ringqvist I. Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud’s phenomenon. Angiology. 1994 Jul;45(7):637-45.
16. Latner AW. 34th annual top 200 drugs. Pharmacy Times. April 1999.
17. Cohen JS. OverDose: The Case Against the Drug Companies. New York, NY: Tarcher/Putnam; 2001.
18. Rogers SA. Tired or Toxic? A Blueprint for Health. Syracuse, NY: Prestige Publishing; 1990.
19. Altura BM, Altura BT. Magnesium in cardiovascular biology. Scientific American Science & Medicine. May/June 1995:28-37.
20. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: relationship to its actions on cardiac, vascular smooth muscle, and endothelial cells. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995.
21. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989 Mar;13(3):22732.
22. Widman L, Wester PO, Stegmayr BK, Wirell M. The dosedependent reduction in blood pressure through administration of magnesium. A double-blind placebo-controlled crossover study. Am J Hypertens. 1993 Jan;6(1):41-5.
23. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol. 1996 Oct 11;56(2):177-83.
24. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr. 1997 Nov;78(5):737-50.
25. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension. 1998 Aug;32(2):2605.
26. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J (Clin Res Ed). 1983 Jun 11;286(6381):1847-9.
27. Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral mag- nesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr. 1994 Jul;60(1):129-35.
28. Seelig MS, Rosanoff A. The Magnesium Factor. New York, NY: Avery Publishers; 2003.
29. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001 Feb;56(2):16370.
30. Galan P, Preziosi P, Durlach V, et al. Dietary magnesium intake in a French adult popula- tion. In: Theophanides T, Anastassopoulou J. Magnesium: Current Status and New Developments: Theoretical, Biological, and Medical Aspects. 1st ed. Dordrecht, Netherlands: Kluwer Academic Publishers; 1997.
31. Cohen JS. Dose discrepancies between the Physicians’ Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events. Arch Intern Med. 2001 Apr 9;161(7):957-64.
32. Cohen JS. Adverse drug effects, compliance, and the initial doses of antihypertensive drugs recommended by the Joint National Committee vs. the Physicians’ Desk Reference. Arch Intern Med. 2001 Mar 26;161(6):880-5.